Dr. D, gratefully retired
@rjdexmd.bsky.social
Retired psychiatrist, celiac, and murderer of several Romance languages, including the official one here in Canada.
Hats off to the Loopy Whisk. Excellent gluten (and lactose) free bread. Great loft, chewy crust, keeps well at room temperature. The magic ingredient is psyllium husk powder.
theloopywhisk.com/2020/04/02/u...
theloopywhisk.com/2020/04/02/u...
July 5, 2025 at 8:30 PM
Hats off to the Loopy Whisk. Excellent gluten (and lactose) free bread. Great loft, chewy crust, keeps well at room temperature. The magic ingredient is psyllium husk powder.
theloopywhisk.com/2020/04/02/u...
theloopywhisk.com/2020/04/02/u...
Happy Father’s Day?
From grandson. I think his mother helped with the selection.
From grandson. I think his mother helped with the selection.
June 15, 2025 at 1:19 PM
Happy Father’s Day?
From grandson. I think his mother helped with the selection.
From grandson. I think his mother helped with the selection.
Family resemblance?
May 28, 2025 at 10:59 PM
Family resemblance?
Fair enough, but you might want to be a little more specific in defining "hot".
April 28, 2025 at 5:00 PM
Fair enough, but you might want to be a little more specific in defining "hot".
I decided to keep it short and only mentioned approval in this email. Sent it to Dr. Steele, copied in everyone else on your list. Thanks, and let's hope for the best. Maybe someone in a hurry might want to crib my note.
April 4, 2025 at 1:05 AM
I decided to keep it short and only mentioned approval in this email. Sent it to Dr. Steele, copied in everyone else on your list. Thanks, and let's hope for the best. Maybe someone in a hurry might want to crib my note.
My email to CTV. Let's let them know how we feel about this.
April 2, 2025 at 3:55 PM
My email to CTV. Let's let them know how we feel about this.
So I sent this letter to the following people at Public Health Ontario: Vice President and Chief, Communicable Disease Control; Medical Director, Communicable Disease Prevention and Control; and Deputy Chief, Communicable Disease Control, Operations and Response.
March 31, 2025 at 1:02 AM
So I sent this letter to the following people at Public Health Ontario: Vice President and Chief, Communicable Disease Control; Medical Director, Communicable Disease Prevention and Control; and Deputy Chief, Communicable Disease Control, Operations and Response.
It might be too early to start an email campaign but here is a rough outline of a letter to be sent to provincial ministers of health. I have mentioned the Ontario government in the letter but I suspect that the same guidance applies to the other provincial health ministries.
March 14, 2025 at 2:15 PM
It might be too early to start an email campaign but here is a rough outline of a letter to be sent to provincial ministers of health. I have mentioned the Ontario government in the letter but I suspect that the same guidance applies to the other provincial health ministries.
Average fuel efficiency of Canadian passenger vehicles is 8.6L/100km; in Finland, 5-6L/100 km. We buy tanks because gas is relatively cheap here. Can't be done? I remember the 1974 oil embargo in the US and drove this cutie.
January 24, 2025 at 2:52 PM
Average fuel efficiency of Canadian passenger vehicles is 8.6L/100km; in Finland, 5-6L/100 km. We buy tanks because gas is relatively cheap here. Can't be done? I remember the 1974 oil embargo in the US and drove this cutie.
Don't be sad, Skippy! You'll find your Captain Canada costume soon.
January 21, 2025 at 4:15 PM
Don't be sad, Skippy! You'll find your Captain Canada costume soon.
From the recent guidance of Canada's immunization advisory committee, politely stating that mRNA vaccines were more promoted than protein-based ones (Novavax). There is no recommendation for one platform over another: ". . . consider the impact of limiting access to only one . . . vaccine platform".
January 13, 2025 at 2:25 PM
From the recent guidance of Canada's immunization advisory committee, politely stating that mRNA vaccines were more promoted than protein-based ones (Novavax). There is no recommendation for one platform over another: ". . . consider the impact of limiting access to only one . . . vaccine platform".